- Marketwired•2 days agoDaxor Corporation Announces Two New Studies From the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society of America 2016 Highlight Unique Ability of BVA to Identify High Risk at Discharge in Hospitalized Heart Failure Patients
Daxor Corporation , an investment company with medical instrumentation and biotechnology operations, announces two new studies presented at the Heart Failure Society of America meeting this month highlighting ...
- Capital Cube•4 days ago
Categories: Yahoo Finance Get free summary analysis Daxor Corp. reports financial results for the half-year ended June 30, 2016. We analyze the earnings along side the following peers of Daxor Corp. – Nephros, Inc. (NEPH-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 1.92 million, Net Earnings of USD 1.64 million. Gross margins ... Read more (Read more...)
- Marketwired•16 days ago
Daxor Corporation , an investment company with medical instrumentation and biotechnology operations, filed its Form N-CSR on Tuesday, August 30, 2016 disclosing its schedule of portfolio holdings as of ...
Daxor Corp. (DXR)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
|Day's Range||7.87 - 8.05|
|52wk Range||7.00 - 8.93|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-9.96|
|Avg Vol (3m)||1,209|
|Dividend & Yield||0.04 (0.50%)|